Real-time index price for S&P 500 Industrials [Sector] (SRIN), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm still bullish on LLY stock.

Asian markets are mostly higher after the U.S. benchmark S&P 500 closed at another record high following a report that the ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

Sourdough and whole wheat are two healthy and widely available bread options. Picking out which bread is best for you depends ...

Married 32-year-old who piled on pounds by binge-eating charts weight loss journey online, now has better skin, new-found ...

Though she “usually [doesn’t] like paparazzi pictures” of herself, she posted a recent one that showed her walking down a sidewalk in Los Angeles.

Five big drugmakers, including LLY and JNJ, are riding innovation, dealmaking and pipeline momentum that could help them keep outperforming in 2026.

Novo Nordisk secured U.S. regulatory approval for its weight-loss pill, giving the Danish drugmaker a shot at reclaiming ...

The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...

The Food and Drug Administration on Monday, Dec. 22, approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight ...